Fusen Pharmaceutical Co (HKSE:01652) Days Sales Outstanding : 65.41 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Fusen Pharmaceutical Co Days Sales Outstanding?

Fusen Pharmaceutical Co's average Accounts Receivable for the six months ended in Dec. 2023 was HK$89.8 Mil. Fusen Pharmaceutical Co's Revenue for the six months ended in Dec. 2023 was HK$250.7 Mil. Hence, Fusen Pharmaceutical Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 65.41.

The historical rank and industry rank for Fusen Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

HKSE:01652' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.7 Med: 49.8 Max: 206.74
Current: 50.58

During the past 9 years, Fusen Pharmaceutical Co's highest Days Sales Outstanding was 206.74. The lowest was 42.70. And the median was 49.80.

HKSE:01652's Days Sales Outstanding is ranked better than
71.24% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs HKSE:01652: 50.58

Fusen Pharmaceutical Co's Days Sales Outstanding increased from Dec. 2022 (40.16) to Dec. 2023 (65.41).

Fusen Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Fusen Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusen Pharmaceutical Co Days Sales Outstanding Chart

Fusen Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

58.01

42.70

49.80

48.72

44.15

Fusen Pharmaceutical Co Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial											69.68	71.41	40.16	45.87	65.41

Competitive Comparison of Fusen Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Fusen Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusen Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fusen Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Fusen Pharmaceutical Co's Days Sales Outstanding falls into.

Fusen Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Fusen Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (77.485	+	72.164)	/	2 )	/	618.65	*	365
=	74.8245					/	618.65	*	365
=	44.15

Fusen Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (107.515	+	72.164)	/	2 )	/	250.662	*	365 / 2
=	89.8395					/	250.662	*	365 / 2
=	65.41

Fusen Pharmaceutical Co (HKSE:01652) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Fusen Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Fusen Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusen Pharmaceutical Co (HKSE:01652) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fusen Pharmaceutical Co Ltd (HKSE:01652) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Urban Industrial Zone, Henan Province, Xichuan County, Zhengzhou, CHN

Website

http://www.fusenyy.com

Fusen Pharmaceutical Co Ltd is engaged in manufacturing shuanghuanglian based cold medicine. The product portfolio company includes shuanghuanglian based cold medicine and which includes oral solutions and shuanghuanglian injections, other PCM and western medicine products which include compound ferrous sulphate granules and flunarizine hydrochloride capsules.

Executives

Cao Changcheng	2201 Interest of corporation controlled by you
Quan Xiufeng	2202 Interest of your spouse
Full Bliss Holdings Limited	2101 Beneficial owner
One Victory Investments Limited	2101 Beneficial owner
Cao Zhiming	2201 Interest of corporation controlled by you
Zhou Peilin	2202 Interest of your spouse
Rayford Global Limited	2306 Nominee for another person
Tct (bvi) Limited	2501 Other
The Core Trust Company Limited	2301 Trustee
First Joint Elegant Limited	2101 Beneficial owner
Fung Wai Sze	2202 Interest of your spouse
Lam Yiu Por	2201 Interest of corporation controlled by you

Fusen Pharmaceutical Co (HKSE:01652) Headlines

No Headlines